Deletion of Cryab increases the vulnerability of mice to the addiction-like effects of the cannabinoid JWH-018 via upregulation of striatal NF-κB expression
Open Access
- 16 March 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14, 1135929
- https://doi.org/10.3389/fphar.2023.1135929
Abstract
Synthetic cannabinoids have exhibited unpredictable abuse liabilities, especially self-administration (SA) responses in normal rodent models, despite seemingly inducing addiction-like effects in humans. Thus, an efficient pre-clinical model must be developed to determine cannabinoid abuse potential in animals and describe the mechanism that may mediate cannabinoid sensitivity. The Cryab knockout (KO) mice were recently discovered to be potentially sensitive to the addictive effects of psychoactive drugs. Herein, we examined the responses of Cryab KO mice to JWH-018 using SA, conditioned place preference, and electroencephalography. Additionally, the effects of repeated JWH-018 exposure on endocannabinoid- and dopamine-related genes in various addiction-associated brain regions were examined, along with protein expressions involving neuroinflammation and synaptic plasticity. Cryab KO mice exhibited greater cannabinoid-induced SA responses and place preference, along with divergent gamma wave alterations, compared to wild-type (WT) mice, implying their higher sensitivity to cannabinoids. Endocannabinoid- or dopamine-related mRNA expressions and accumbal dopamine concentrations after repeated JWH-018 exposure were not significantly different between the WT and Cryab KO mice. Further analyses revealed that repeated JWH-018 administration led to possibly greater neuroinflammation in Cryab KO mice, which may arise from upregulated NF-κB, accompanied by higher expressions of synaptic plasticity markers, which might have contributed to the development of cannabinoid addiction-related behavior in Cryab KO mice. These findings signify that increased neuroinflammation via NF-κB may mediate the enhanced addiction-like responses of Cryab KO mice to cannabinoids. Altogether, Cryab KO mice may be a potential model for cannabinoid abuse susceptibility.Funding Information
- Ministry of Food and Drug Safety (19182MFDS410 22214MFDS252)
- National Research Foundation of Korea (2020R1F1A1075633)
This publication has 140 references indexed in Scilit:
- Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in HumansPLOS ONE, 2013
- Opioid Activation of Toll-Like Receptor 4 Contributes to Drug ReinforcementJournal of Neuroscience, 2012
- Brain cannabinoid CB2 receptors modulate cocaine's actions in miceNature Neuroscience, 2011
- False positive in the intravenous drug self-administration test in C57BL/6J miceBehavioural Pharmacology, 2011
- The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effectsNeuropharmacology, 2011
- Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disordersNeuroscience, 2010
- Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial CellsOnline Journal of Public Health Informatics, 2010
- Substance Use Disorders in Schizophrenia--Clinical Implications of ComorbiditySchizophrenia Bulletin, 2009
- EEG of chronic marijuana users during abstinence: Relationship to years of marijuana use, cerebral blood flow and thyroid functionClinical Neurophysiology, 2008
- Glutamatergic substrates of drug addiction and alcoholismBiochemical Pharmacology, 2008